Article | July 21, 2021

Direct-To-Patient Solutions: Technology To Help Improve Patient Recruitment And Retention

Source: YPrime

By Ryan Ridge, Senior Director, IRT Operations, YPrime

patient BYOD iStock-1127904439

Ongoing patient recruitment and retention challenges were intensified by the Covid-19 global pandemic. Adoption of alternative trial designs and technology solutions accelerated among clinical research professionals looking for ways to make it easier for patients to participate in clinical  trials, regardless of their location. One alternative trial design is the Direct-to-Patient (DtP) strategy, where study drug is shipped directly to the patient, and technology solutions play a critical role in managing the supply chain and ensuring that, at the end of the lifecycle, there is full accountability. This article explores what DtP is, as well as its benefits and complexities.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: